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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S265Conclusions: Increased vibratory acuity was associatedwith both lower
PPTs and the presence of TS in this large cohort of persons with or at risk
of knee OA. Increased vibratory acuity also appeared to modify the
association between low PPT and radiographic OA in this cross-
sectional analysis. Thus vibratory sense may be an additional somato-
sensorymeasurewith relevance to central sensitization and nociceptive
processing in persons with knee OA.Table
Relationship between VPT, PPT with tibiofemoral radiographic OA
VPT and PPT combo Adjusted* Prevalence
Ratio (95% CI)
p-value
PPT VPT
Low Low 1.36 (1.16-1.60) 0.0001
Middle 1.07 (0..95-1.20) 0.3
High 1.19 (0.97-1.45) 0.1
Middle Low 0.99 (0.86-1.14) 0.8
Middle REF
High 1.03 (0.90-1.90) 0.6
High Low 1.11 (0.76-1.61) 0.6
Middle 1.05 (0.91-1.21) 0.5
High 1.17 (0.92-1.49) 0.2
*Adjusted for age, sex, BMI, race, clinical site, CES-D, widespread pain, and
catastrophizing513
CHARACTERIZATION OF MONOSODIUM IODOACETATE-INDUCED
LOCOMOTOR ACTIVITY IMPAIRMENT IN RATS
A. Pekcec, L. Corradini, H. Doods. Boehringer Ingelheim Pharma GmbH &
Co. KG, Biberach an der Riss, Germany
Purpose: Activity measurement in rodents has been suggested as
a novel approach to evaluate analgesic effects of drugs on ongoing pain
without using reﬂexive, withdrawal threshold measures. In the present
studies, we characterized spontaneous activity deﬁcits in the rat mon-
osodium iodoacetate (MIA) model of osteoarthritis pain and compared
activity deﬁcits with those induced in a different inﬂammatory model
of pain, the Complete Freunds Adjuvant (CFA) model. Furthermore, the
effect of standard analgesics onMIA or CFA induced activity deﬁcits was
evaluated and compared.
Methods: Male Wistar-Han rats (Charles River, Germany) were used to
induce knee joint inﬂammation by bilateral injections of 3mg/kg MIA
(Sigma, Germany) solved in 50ml saline. Three days later locomotor
activity was observed over 30 minutes in an open ﬁeld by using an
activity monitoring system (Harvard Apparatus, MA, USA). Sham rats
received i.e. administration of saline instead of MIA injection. For the
CFA studies, 100mg of CFA (Sigma, Germany) was injected in a total
volume of 100ml intraplantar into one or both paws. Locomotor activity
was determined the next day. Sham treated animals received the same
amount of intraplantar saline injections.
Results: Rats withMIA injection showed a decrease of the total distance
travelled, rearing frequency as well as the total rearing time compared
to Sham treated animals and naive controls. Single-dose administration
of different doses of indomethacin or celebrex (that are efﬁcacious in
evoked measures of pain) did not attenuate activity deﬁcits induced by
MIA. Also, repeated treatment with celebrex over 3 days did not
attenuate MIA-induced locomotor activity impairments. Acute p.o.
administration of tramadol reduced MIA induced activity deﬁcits
without impairment of activity in controls whereas subcutaneous
injections of morphine impaired locomotor activity in both MIA and
control rats. In contrast, single-dose administration of indomethacin,
celebrex and tramadol (that are efﬁcacious in evoked measures of pain)
attenuated activity deﬁcits in CFA rats without inﬂuencing activity
parameters in control animals. Similar to MIA rats, morphine impaired
locomotor activity in control rats as well as CFA rats.
Conclusions: The data of this study indicate impaired spontaneous
activity in the rat MIA model of inﬂammatory osteoarthritis. Although
these activity deﬁcits appear to be less pronounced as compared to
those observed in the intraplantar CFA model, the treatment response
to different clinically used analgesics differs suggesting major differ-
ences in the underlying inﬂammatory processes. The data moreover
suggest that activity measurements in the rodent MIA model of oste-
oarthritis present as an interesting functional behavioral readout foranalgesic drug effects that does not require habituation of the animal
and is thus less prone to observation subjectivity.
The current study was done as a BI contribution to the “EUROPAIN”
project within the European Consortium “Innovative Medicine Initia-
tive”. The authors thank Andreas Sterner for technical assistance.
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STRUCTURAL BRAIN ALTERATIONS IN INDIVIDUALS WITH CHRONIC
JOINT PAIN
M. de Kruijf, D. Bos, F.J. Huijgen, A. Hofman, M.W. Vernooij, A.G.
Uitterlinden, M.A. Ikram, J.B. van Meurs. Erasmus MC, Rotterdam, The
Netherlands
Purpose: The severity of pain reported by OA patients does not always
reﬂect the extent of detectable joint pathology. Identiﬁcation of the
areas of the brain involved in development of chronic joint pain could
provide insight into these observed discrepancies. Long term changes in
the brain can be detected by examining structural brain changes, which
reﬂect adaptive reorganization of the nervous system. Previous studies
examining structural brain alterations in subjects with chronic (joint)
pain were all performed in small case-control studies, using not more
than 60 patients and usually using voxel based techniques which may
be subject to false positive ﬁndings due to multiple testing. In the
current study, we examined brain volume alterations in a large pop-
ulation based study (n¼3967) and used state-of-the art tools to
segment brain structures.
Methods: This study was performed in the Rotterdam study,
a prospective population-based cohort study of individuals aged 45
years and over. In 3967 subjects, in whom magnetic resonance imaging
(MRI) of the brain was performed, brain volumes were segmented and
quantiﬁed in millilitres. We ﬁrst investigated the association of chronic
joint pain with global volumes of grey matter; after which we
segmented the brain volumes into four main lobes (frontal, temporal,
parietal and occipital). Subsequently, we investigated the association of
chronic joint pain with volumes of structures that are part of the limbic
system or are involved in signal processing (hippocampus, amygdala,
thalamus and caudate). Chronic joint painwas deﬁned as having pain in
one or more joints for more than half of the days in the last six weeks,
and the subjects should have visited a medical doctor for this pain.
Association analyses were performed with Z-score normalised volumes,
stratiﬁed on gender and adjusted for intracranial volume, age and the
presence of depression according to the self reporting CES-D scale.
Results: A total of 3383 subjects (1527 males and 1856 females) with
both MRI and pain data were available for analysis. Chronic joint pain
was present in 27% of the male subjects and in 42% of the female
subjects. Total grey matter volume was signiﬁcantly smaller in female
subjects with chronic joint pain (Beta -0.06; p-value 0.031), which was
primarily located in the temporal lobe (Beta -0.08; p-value 0.011) and
a trend for the frontal lobe (Beta 0.06; p-value 0.057). Since involve-
ment of the frontal and temporal lobe suggested involvement of the
limbic system, we subsequently studied these structures further. Again
only in females, a signiﬁcant smaller hippocampal volume was found
(Beta -0.10; p-value 0.003). All these association were independent of
age and presence of depression symptoms. No clear associations with
the studied brain structures were found in males.
Conclusions: We found a signiﬁcantly smaller grey matter volumes in
the brain of females with chronic joint pain, speciﬁcally in the temporal
lobe and hippocampus. The location of this identiﬁed areas point
towards the involvement of emotional processing, in females with
chronic joint pain. The fact that this is not found in men might indicate
a sexually dimorphic handling of pain, which might have consequences
for the treatment of pain between the two sexes.515
INVESTIGATING A ROLE FOR TNF-ALPHA IN MCP-1 UPREGULATION
IN THE KNEE AND DRG IN THE DMM MODEL
R.E. Miller, P.B. Tran, A.-M. Malfait. Rush Univ. Med. Ctr., Chicago, IL, USA
Purpose: We recently reported that MCP-1/CCR2 signaling mediates
the development of movement-provoked pain in a mouse model of
osteoarthritis (OA) induced by destabilization of the medial meniscus
(DMM). At 8 weeks post DMM, monocyte chemoattractant protein
(MCP)-1 and CCR2 were upregulated in the innervating dorsal root
ganglia (DRG), and this correlated with the onset of decreased
